Source: Fortune.com
Summary
David Protein’s CEO, Peter Rahal, believes that the rise of GLP-1 receptor agonists has ended traditional diet trends. Instead, people are turning to these medications for weight loss, and the food industry is adapting. As a result, protein has become increasingly popular, with many companies, including David Protein, capitalizing on the trend. However, this has led to a shortage of whey protein, causing prices to soar.
Our Reading
The numbers tell one story.
David Protein’s CEO, Peter Rahal, is familiar with food trends, having created RXBar and sold it to Kellogg’s for $600 million. He believes that GLP-1s have changed the nature of weight loss, making traditional diet trends obsolete. Instead, people are turning to protein-packed snacks to preserve muscle mass while taking GLP-1s. The rise of “proteinmaxxing” has led to a shortage of whey protein, causing prices to increase by 40% in just a few months.
The strategy enters a familiar phase: companies are adapting to the new trend, with some changing recipes to use alternative protein sources. David Protein plans to ride the wave, expecting $300 million in revenue this year.
When a trend gets a name, it’s already a business plan.
Author: Evan Null
